Skip to Content


In the US, Rimactane (rifampin systemic) is a member of the drug class rifamycin derivatives and is used to treat Bartonellosis, Endocarditis, Haemophilus influenzae Prophylaxis, Legionella Pneumonia, Leprosy, Leprosy - Borderline, Leprosy - Tuberculoid, Meningitis, Meningococcal Meningitis Prophylaxis, Nasal Carriage of Staphylococcus aureus, Tuberculosis - Active, Tuberculosis - Latent and Tuberculosis - Prophylaxis.

US matches:

UK matches:

Ingredient matches for Rimactane


Rifampicin is reported as an ingredient of Rimactane in the following countries:

  • Bangladesh
  • Egypt
  • India
  • Indonesia
  • Lithuania
  • Oman
  • South Africa
  • United Kingdom

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.